Table 2

The effects of baseline ICH volume (ICHV), ICH volume as a ratio of ICV (ICHV/ICV), ICH volume as a ratio of CPV (ICHV/CPV) (all measured by SAS), midline shift and cistern effacement on day 90 mRS, day 4 death and acute neurological deterioration

VariableDay 90 mRS†Day 4 deathAcute neurological deterioration*
OR (95% CI)P valueOR (95% CI)P valueOR (95% CI)P value
ICHV (per 10 mL)1.47 (1.14 to 1.88)0.0031.15 (1.01 to 1.29)0.0311.20 (1.01 to 1.42)0.036
ICHV/ICV
(per 1% increase)
1.79 (1.24 to 2.59)0.0021.24 (1.06 to 1.47)0.0091.40 (1.11 to 1.78)0.005
ICHV/CPV (per 1% increase)1.63 (1.20 to 2.21)0.0061.21 (1.06 to 1.37)0.0051.33 (1.09 to 1.62)0.005
Midline shift (per mm increase)1.46 (1.11 to 1.93)0.0071.17 (1.04 to 1.31)0.0091.36 (1.06 to 1.73)0.014
Cistern effacement (per one point increase from total of 4)1.76 (1.01 to 3.09)0.0482.28 (1.53 to 3.41)<0.0012.03 (1.10 to 3.76)0.024
  • Comparisons by binary logistic regression shown as OR with 95% CIs, with adjustment for age, sex, GCS, systolic blood pressure, time from stroke onset to CT scan, treatment assignment (GTN vs no GTN).

  • *Acute neurological deterioration which was defined as an increase in National Institutes of Health Stroke Scale of ≥4 or a decrease in GCS of ≥2.25

  • †OR of mRS score >3

  • CPV, cerebral parenchymal volume; GCS, Glasgow Coma Scale; GTN, glyceryl trinitrate; ICHV, ICH volume; ICV, intracranial volume; mRS, modified Rankin scale.